Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Argus Health
AstraZeneca
Medtronic
Federal Trade Commission
Fish and Richardson
Chinese Patent Office
Cipla
Harvard Business School
Express Scripts

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,056,886

« Back to Dashboard

Which drugs does patent 7,056,886 protect, and when does it expire?

Patent 7,056,886 protects GATTEX KIT and is included in one NDA.

This patent has sixteen patent family members in twelve countries.
Summary for Patent: 7,056,886
Title:GLP-2 formulations
Abstract: The invention is directed to formulations of GLP-2 peptides and analogs thereof exhibiting superior stability following storage and/or exposure to elevated temperatures. The GLP-2 compositions comprise a GLP-2 peptide or an analog thereof, a phosphate buffer, L-histidine, and mannitol.
Inventor(s): Isaacs; Indu J. (Andover, MA)
Assignee: NPS Allelix, Corp. (Mississauga, CA)
Application Number:09/750,022
Patent Claim Types:
see list of patent claims
Formulation; Process; Use; Device;

Drugs Protected by US Patent 7,056,886

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Nps Pharms Inc GATTEX KIT teduglutide recombinant POWDER;SUBCUTANEOUS 203441-001 Dec 21, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y TREATMENT OF ADULT PATIENTS WITH SHORT BOWEL SYNDROME WHO ARE DEPENDENT ON PARENTERAL SUPPORT ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,056,886

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9930882Dec 30, 1999

International Patents Family Members for US Patent 7,056,886

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany 60033437 ➤ Try a Free Trial
Denmark 1246639 ➤ Try a Free Trial
European Patent Office 1246639 ➤ Try a Free Trial
Spain 2282161 ➤ Try a Free Trial
United Kingdom 9930882 ➤ Try a Free Trial
Japan 2003519195 ➤ Try a Free Trial
Hong Kong 1050142 ➤ Try a Free Trial
Japan 2012116861 ➤ Try a Free Trial
Japan 5001498 ➤ Try a Free Trial
Canada 2395814 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Merck
UBS
Baxter
Mallinckrodt
Fuji
Chinese Patent Office
US Department of Justice
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot